Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Circulation

• Publication date

  2013-07-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIR.0b013e31829b2be6PMID 23775258
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• Endocrine complications in patients with thalassaemia major

  2013cited by this paper
• Comparison of biventricular dimensions and function between pediatric sickle‐cell disease and thalassemia major patients without cardiac iron

  2013cited by this paper
• Exercise performance in thalassemia major: Correlation with cardiac iron burden

  2013cited by this paper
• Amlodipine reduces cardiac iron overload in patients with thalassemia major: a pilot trial.

  2013cited by this paper
• International survey of T2* cardiovascular magnetic resonance in β-thalassemia major

  2013cited by this paper
• On myocardial siderosis and left ventricular dysfunction in hemochromatosis

  2013cited by this paper
• Correlation of NT-proBNP levels and cardiac iron concentration in patients with transfusion-dependent thalassemia major.

  2013cited by this paper
• Combined chelation therapy with deferasirox and deferoxamine in thalassemia.

  2013cited by this paper
• Focused Update : ACCF / AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults

  2013cited by this paper
• Ferric iron uptake into cardiomyocytes of β-thalassemic mice is not through calcium channels

  2013cited by this paper
• Deferasirox: pharmacokinetics and clinical experience

  2012cited by this paper
• Feasibility, reproducibility, and reliability for the T*2 iron evaluation at 3 T in comparison with 1.5 T

  2012cited by this paper
• Thalassaemia in pregnancy.

  2012cited by this paper
• Ultrafiltration in decompensated heart failure with cardiorenal syndrome.

  2012cited by this paper
• Left and right ventricular function and volume assessment in young thalassemia major patients with no related myocardial iron overload

  2012cited by this paper
• Iron overload in non-transfusion-dependent thalassemia: a clinical perspective.

  2012cited by this paper
• Sickle‐cell disease and the heart: review of the current literature

  2012cited by this paper
• T‐type calcium channel blockade improves survival and cardiovascular function in thalassemic mice

  2012cited by this paper
• A Multicenter, Randomized, Open-Label Trial Evaluating Deferasirox Compared with Deferoxamine for the Removal of Cardiac Iron in Patients with β-Thalassemia Major and Iron Overload (CORDELIA).

  2012cited by this paper
• Renal aspects of thalassaemia a changing paradigm

  2012cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  2012cited by this paper
• Electrocardiographic consequences of cardiac iron overload in thalassemia major

  2012cited by this paper
• Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia major

  2012cited by this paper
• Diuretics and ultrafiltration in acute decompensated heart failure.

  2012cited by this paper
• Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort.

  2012cited by this paper
• Long‐term use of deferiprone significantly enhances left‐ventricular ejection function in thalassemia major patients

  2012cited by this paper
• Left and right ventricle assessment with Cardiac CT: validation study vs. Cardiac MR

  2012cited by this paper
• Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major

  2012cited by this paper
• Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance

  2011cited by this paper
• Dispersion of repolarization and beta‐thalassemia major: the prognostic role of QT and JT dispersion for identifying the high‐risk patients for sudden death

  2011cited by this paper
• Intermediate-Term Evaluation Of A Pratical Chelation Protocol Based On Stratification Of Thalassemic Patients By Serum Ferritin And Magnetic Resonance Imaging Cardiac T2*

  2011cited by this paper
• On T2* Magnetic Resonance and Cardiac Iron

  2011cited by this paper
• Correlation of NT-ProBNP Levels and Cardiac Iron Concentration in Patients with Transfusion-Dependent Thalassemia Major,

  2011cited by this paper
• Iron overload in polytransfused patients without heart failure is associated with subclinical alterations of systolic left ventricular function using cardiovascular magnetic resonance tagging

  2011cited by this paper
• Relationship between labile plasma iron, liver iron concentration and cardiac response in a deferasirox monotherapy trial

  2011cited by this paper
• Survival in a large cohort of Greek patients with transfusion‐dependent beta thalassaemia and mortality ratios compared to the general population

  2011cited by this paper
• Revisiting the relationship between vitamin D deficiency, cardiac iron and cardiac function in thalassemia major

  2011cited by this paper
• Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload

  2011cited by this paper
• Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a T2* magnetic resonance imaging study

  2011cited by this paper
• Interdependence of cardiac iron and calcium in a murine model of iron overload.

  2011cited by this paper
• Quantitative computed tomography assessment of transfusional iron overload

  2011cited by this paper
• Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging

  2011cited by this paper
• Training and accreditation in cardiovascular magnetic resonance in Europe: a position statement of the working group on cardiovascular magnetic resonance of the European Society of Cardiology.

  2011cited by this paper
• Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century

  2011cited by this paper
• Iron-chelating therapy for transfusional iron overload.

  2011cited by this paper
• Long-term safety and efficacy of deferasirox (Exjade®) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease

  2011cited by this paper
• Reversible Fanconi syndrome in a pediatric patient on deferasirox

  2011cited by this paper
• Iron Overload Decreases CaV1.3-Dependent L-Type Ca2+ Currents Leading to Bradycardia, Altered Electrical Conduction, and Atrial Fibrillation

  2011cited by this paper
• Renal dysfunction in patients with thalassaemia

  2011cited by this paper
• On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure

  2011cited by this paper
• Detection of Early Cardiac Dysfunction in Patients with Beta Thalassemia by Tissue Doppler Echocardiography

  2011cited by this paper
• Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment.

  2011cited by this paper
• Oral chelators in transfusion-dependent thalassemia major patients may prevent or reverse iron overload complications.

  2011cited by this paper
• Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload

  2011cited by this paper
• Impact of magnetic resonance imaging on cardiac mortality in thalassemia major

  2011cited by this paper
• Value of black blood T2* cardiovascular magnetic resonance

  2011cited by this paper
• A synopsis of current care of thalassaemia major patients in Hong Kong.

  2011cited by this paper
• Contemporary Reviews in Cardiovascular Medicine Iron Overload Cardiomyopathy in Clinical Practice

  2011cited by this paper
• Is Deferasirox Implicated in Multiple Organ Failure in a Patient With Homozygous β-Thalassemia?

  2011cited by this paper
• Iron-chelating therapy for transfusional iron overload.

  2011cited by this paper
• Controversies in cardiovascular medicine Drugs vs . ablation for the treatment of atrial fibrillation : the evidence supporting catheter ablation

  2010cited by this paper
• A Decade Follow-up of a Thalassemia Major (TM) Cohort Monitored by Cardiac Magnetic Resonance Imaging (CMR): Significant Reduction In Patients with Cardiac Iron and In Total Mortality

  2010cited by this paper
• Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload

  2010cited by this paper
• Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel.

  2010cited by this paper
• Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone.

  2010cited by this paper
• Observational study of iron overload as assessed by magnetic resonance imaging in an adult population of transfusion‐dependent patients with β thalassaemia: significant association between low cardiac T2* < 10 ms and cardiac events

  2010cited by this paper
• International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers

  2010cited by this paper
• Cardiovascular MRI in thalassemia major

  2010cited by this paper
• Incidence of Hepatocellular Carcinoma in a Thalassemia Unit

  2010cited by this paper
• Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia.

  2010cited by this paper
• Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment.

  2010cited by this paper
• THE ROLE OF Treg CELLS AND FoxP3 EXPRESSION IN IMMUNITY OF β-THALASSEMIA MAJOR AND β-THALASSEMIA TRAIT PATIENTS

  2010cited by this paper
• Combining two orally active iron chelators for thalassemia

  2010cited by this paper
• Testosterone Deficiency and Exercise Intolerance in Heart Failure: Treatment Implications

  2010cited by this paper
• Oral iron chelators.

  2010cited by this paper
• Follow‐up report on the 2‐year cardiac data from a deferasirox monotherapy trial

  2010cited by this paper
• Acquired proximal renal tubular dysfunction in β-thalassemia patients treated with deferasirox.

  2010cited by this paper
• Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.

  2010cited by this paper
• The efficacy of tissue Doppler imaging in predicting myocardial iron load in patients with beta-thalassemia major: correlation with T2* cardiovascular magnetic resonance

  2010cited by this paper
• Pregnancy and β-thalassemia: an Italian multicenter experience

  2010cited by this paper
• Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone.

  2010cited by this paper
• Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major

  2010cited by this paper
• Separate MRI quantification of dispersed (ferritin‐like) and aggregated (hemosiderin‐like) storage iron

  2010cited by this paper
• Pathogenesis and management of iron toxicity in thalassemia

  2010cited by this paper
• Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

  2010cited by this paper
• Retrospective Study on the Combination of Desferrioxamine and Deferasirox for Treatment of Iron-overloaded Thalassemic Patients: First Evidence of More Than 2 Years

  2010cited by this paper
• Fertility potential in thalassemia major women: current findings and future diagnostic tools

  2010cited by this paper
• Hyperchloremic Metabolic Acidosis Due to Deferasirox in a Patient with Beta Thalassemia Major

  2010cited by this paper
• Predicting pituitary iron and endocrine dysfunction

  2010cited by this paper
• Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

  2010cited by this paper
• Relation of myocardial T2* to right ventricular function in thalassaemia major.

  2010cited by this paper
• HFSA 2010 Comprehensive Heart Failure Practice Guideline.

  2010cited by this paper
• Hepatocellular carcinoma in patients with thalassaemia syndromes: clinical characteristics and outcome in a long term single centre experience

  2010cited by this paper
• Ambulatory blood pressure profile in anemic hypertensive patients.

  2010cited by this paper
• Combined iron chelation therapy

  2010cited by this paper
• The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores.

  2010cited by this paper
• High prevalence of "biochemical" adrenal insufficiency in thalassemics: is it a matter of different testings or decreased cortisol binding globulin?

  2010cited by this paper
• Pancreatic iron loading predicts cardiac iron loading in thalassemia major.

  2009cited by this paper

• Indian College of Hematology (ICH)& Indian Council of Medical Research (ICMR) Joint Consensus Document on Management and Control of Sickle Cell Disease in India

  2026cites this paper
• Left ventricular wall motion abnormalities in transfusion-dependent thalassemia: A large cross-sectional cardiovascular magnetic resonance study.

  2026cites this paper
• Cardiovascular magnetic resonance derived pulmonary capillary wedge pressure in beta-thalassemia major: Clinical correlates and association with cardiac complications.

  2025cites this paper
• Cardiac injury caused by iron overload in thalassemia

  2025cites this paper
• Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects

  2025cites this paper
• Combinatorial approach to treat iron overload cardiomyopathy in pediatric patients with thalassemia-major: A systematic review and meta-analysis

  2025cites this paper
• Detection of Liver Iron Overload in Patients With Thalassemia With Ultra-short Echo Time MR Imaging on 3.0T.

  2025cites this paper
• Cardiac magnetic resonance T2 mapping and T2* mapping for myocardial iron detection in iron-water phantom models and pediatric patients with transfusion-dependent thalassemia: a comparison study

  2025cites this paper
• Ventricular Tachycardia Caused by Moderator Band in a Patient with Thalassemia Major

  2025cites this paper
• Left ventricular diastolic and systolic functions by cardiac magnetic resonance in beta-thalassemia major: correlation with clinical findings and cardiac complications

  2025cites this paper
• Cardiac Conduction Disorders Due to Acquired or Genetic Causes in Young Adults: A Review of the Current Literature

  2025cites this paper
• Pregnancy Outcomes in Women With Thalassemia Trait: A Multicenter Cohort Study

  2025cites this paper
• Prevalence and Correlates of Dilated and Non-Dilated Left Ventricular Cardiomyopathy in Transfusion-Dependent Thalassemia: Data from a National, Multicenter, Observational Registry

  2025cites this paper
• Concordance, comfort and care: how advances in subcutaneous infusion needle design are transforming thalassaemia treatment in the UK.

  2025cites this paper
• Frequency of cardiac complications in Beta-thalassemia patients at National Institute of Child Health, Karachi, Pakistan

  2025cites this paper
• Iron chelation therapy in myelodysplastic syndromes and allogeneic hematopoietic cell transplantation, a delicate balance.

  2025cites this paper
• Irisin Protects Against Diabetic Cardiomyopathy by Suppressing Ferroptosis

  2025cites this paper
• A Contemporary Review of Clinical Manifestations, Evaluation, and Management of Cardiac Complications of Iron Overload

  2025cites this paper
• Beta-Thalassemia Major With Iron Overload Cardiomyopathy and Refractory Cardiogenic Shock Requiring Mechanical Circulatory Support

  2025cites this paper
• From treatment to biology and back: managing iron overload in transfused hemoglobinopathies.

  2025cites this paper
• Global Myocardial Wall Thickness in Transfusion-Dependent Thalassemia: A Cross-Sectional MRI Analysis

  2025cites this paper
• Performance and Correlations of Myocardial Contraction Fraction Derived From MRI in Transfusion‐Dependent Thalassemia Patients

  2025cites this paper
• Targeting mitochondrial dynamics emerges as an effective strategy of cardioprotection against trastuzumab-induced mitochondrial functional aberrations and cardiotoxicity in rats.

  2025cites this paper
• Diagnostic and Prognostic Testing in Heart Failure.

  2025cites this paper
• The Risk of Rapid Deterioration of Sepsis in the Patient with Non-Transfusion-Dependent Thalassemia: A Case Report

  2025cites this paper
• A Mixed-attention Network for Automated Interventricular Septum Segmentation in Bright-blood Myocardial T2* MRI Relaxometry in Thalassemia.

  2025cites this paper
• What is the importance of monitoring iron levels in different organs over time with magnetic resonance imaging in transfusion-dependent thalassemia patients?

  2025cites this paper
• Prospective Assessment of Cardiac Iron Deposition, Morphology, and Function by Magnetic Resonance Imaging in Non-Transfusion-Dependent and Neo-Transfusion-Dependent Thalassemia

  2025cites this paper
• Cardiac Manifestations of Hemochromatosis.

  2024cites this paper
• Differential impact of glucose abnormalities and iron overload in TM (TM) and TI(TI): A comparative analysis of diagnostic approaches and management strategies for optimized care

  2024cites this paper
• Reproductive Health in Women with Major β-Thalassemia: Evaluating Ovarian Reserve and Endocrine Complications

  2024cites this paper
• The predicting formula and scoring system for cardiac iron overload for thalassaemia children: Study from a middle-income country

  2024cites this paper
• Early detection of myocardial iron overload in patients with β-thalassemia major using cardiac magnetic resonance T1 mapping.

  2024cites this paper
• Early Detection of Myocardial Involvement in Thalassemia Intermedia Patients: Multiparametric Mapping by Magnetic Resonance Imaging

  2024cites this paper
• MALAT1: A novel hypothesis on the pathology of vascular injury in patients with β-thalassemia

  2024cites this paper
• Beta-Thalassemia Major and Myocardial Iron Overload: A Longitudinal Study with Magnetic Resonance Imaging

  2024influential citation
• Soluble fms-like tyrosine kinase-1 as a predictive marker for iron overload in adult patients with transfusion-dependent beta-thalassemia major

  2024cites this paper
• Liver steatosis in patients with transfusion‐dependent thalassaemia

  2024cites this paper
• Evaluation of myocardial strain using cardiovascular magnetic resonance imaging in patients with β-thalassemia major

  2024cites this paper
• The Effects and Safety of Silymarin on β-thalassemia in Children and Adolescents: A Systematic Review based on Clinical Trial Studies.

  2024cites this paper
• Iron overload: the Achilles heel of β- thalassemia.

  2024cites this paper
• Recent advances of traditional Chinese medicine against cardiovascular disease: overview and potential mechanisms

  2024cites this paper
• Guideline for the Management of Conception and Pregnancy in Thalassaemia Syndromes: A British Society for Haematology Guideline

  2024cites this paper
• FTO alleviated ferroptosis in septic cardiomyopathy via mediating the m6A modification of BACH1.

  2024cites this paper
• Magnetic Resonance Evaluation of Tissue Iron Deposition and Cardiac Function in Adult Regularly Transfused Thalassemia Intermedia Compared with Thalassemia Major Patients

  2024cites this paper
• Factor analysis of hepcidin on cardiac iron overload and fibrosis among thalassemia major children

  2024cites this paper
• Global, regional, and national burden of thalassemia, 1990–2021: a systematic analysis for the global burden of disease study 2021

  2024cites this paper
• How I manage iron overload in the hemopoietic cell transplantation setting.

  2024cites this paper
• The Role of Ferroptosis in Atrial Fibrillation: A Promising Future

  2024cites this paper
• Multiparametric cardiac magnetic resonance in patients with thalassemia intermedia: new insights from the E-MIOT network

  2024cites this paper
• Multiparametric Cardiac Magnetic Resonance Assessment in Sickle Beta Thalassemia

  2024cites this paper
• Left and right atrioventricular coupling index in patients with beta-thalassemia major

  2024cites this paper
• Ferroptosis and metabolic syndrome and complications: association, mechanism, and translational applications

  2024cites this paper
• The molecular mechanisms and potential drug targets of ferroptosis in myocardial ischemia-reperfusion injury.

  2024cites this paper
• Management of iron overload: lessons from transfusion-dependent hemoglobinopathies.

  2024cites this paper
• Emerging regulatory mechanisms in cardiovascular disease: Ferroptosis.

  2024cites this paper
• Evaluation of iron overload in visceral organs in thalassemia patients by point shear-wave elastography

  2024cites this paper
• USP38 exacerbates myocardial injury and malignant ventricular arrhythmias after ischemia/reperfusion by promoting ferroptosis through the P53/SLC7A11 pathway.

  2024cites this paper
• Global longitudinal strain by cardiac magnetic resonance is associated with cardiac iron and complications in beta-thalassemia major patients.

  2024cites this paper
• Perturbations in lipid metabolism and gut microbiota composition precede cardiac dysfunction in a mouse model of thalassemia

  2023cites this paper
• Secondary Hemochromatosis Leading to Acute Coronary Syndrome in a Thalassemic Patient

  2023cites this paper
• Therapeutic Approaches Targeting Ferroptosis in Cardiomyopathy

  2023cites this paper
• Cardiac complications in thalassemia throughout the lifespan: Victories and challenges

  2023cites this paper
• Role of cardiac magnetic resonance T1 mapping in comparison to T2* for cardiac iron overload assessment in transfusion-dependent thalassemia major patients

  2023cites this paper
• Ferroptosis Involved in Cardiovascular Diseases: Mechanism Exploration of Ferroptosis' Role in Common Pathological Changes.

  2023cites this paper
• Vagus nerve stimulation and acetylcholinesterase inhibitor donepezil provide cardioprotection against trastuzumab-induced cardiotoxicity in rats by attenuating mitochondrial dysfunction.

  2023cites this paper
• A hybrid framework based on knowledge distillation for explainable disease diagnosis

  2023cites this paper
• Correlation of Magnesium Level with Cardiac and Hepatic Hemosiderosis Measured by T2*MRI Technique and Age in Patients with Thalassemia Major

  2023cites this paper
• Ferroptosis in cardiac hypertrophy and heart failure.

  2023cites this paper
• Impact of the COVID-19 Pandemic on Iron Overload Assessment by MRI in Patients with Hemoglobinopathies: The E-MIOT Network Experience

  2023cites this paper
• Association Between β-thalassemia and Atrial Fibrillation: Insights from the United States National Inpatient Sample

  2023cites this paper
• Phenotypic Clustering of Beta-Thalassemia Intermedia Patients Using Cardiovascular Magnetic Resonance

  2023cites this paper
• T2* map at cardiac MRI reveals incidental hepatic and cardiac iron overload.

  2023cites this paper
• Amlodipine rescues advanced iron overload cardiomyopathy in hemojuvelin knockout murine model: Clinical implications

  2023cites this paper
• The impact of HCV chronic positivity and clearance on extrahepatic morbidity in thalassemia major patients: an observational study from MIOT Network.

  2023cites this paper
• Hidden in plain sight: complex tachycardias in a young thalassaemia patient.

  2023cites this paper
• Prenatal Diagnosis of Fetal Heart Failure

  2023cites this paper
• Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia

  2023cites this paper
• Electrophysiological properties and heart rate variability of patients with thalassemia major in Jakarta, Indonesia

  2023cites this paper
• Quantitative MRI in cardiometabolic disease: From conventional cardiac and liver tissue mapping techniques to multi-parametric approaches

  2023cites this paper
• Imaging in Heart Failure with Preserved Ejection Fraction: A Multimodality Imaging Point of View

  2023cites this paper
• Cardiovascular Complications in β-Thalassemia: Getting to the Heart of It

  2023cites this paper
• Four‑Dimensional Echocardiographic Evaluation of Cardiac Iron Overload in Patients with Beta-Thalassemia Major

  2023cites this paper
• Thalassaemia—A global view

  2023cites this paper
• Clinical Complications and Their Management.

  2023cites this paper
• Multi-Parametric Cardiac Magnetic Resonance for Prediction of Heart Failure Death in Thalassemia Major

  2023cites this paper
• Left ventricular global function index is associated with myocardial iron overload and heart failure in thalassemia major patients

  2023cites this paper
• Speckle tracking echocardiography and β-thalassemia major. A systematic review

  2023cites this paper
• Low Vitamin D Levels Are Associated with Increased Cardiac Iron Uptake in Beta-Thalassemia Major

  2023cites this paper
• Importance of Autophagy in Mediating Cellular Responses to Iron Overload in Cardiomyocytes

  2022cites this paper
• Left atrial deformation indices in β-thalassemia major patients

  2022cites this paper
• Correlation between Myocardial Iron Overload Detected by CMRT2* and Left Ventricular Function Assessed by Tissue Doppler Imaging in Patients with Thalassemia Major

  2022cites this paper
• The role of cardiac T2* magnetic resonance imaging in the assessment of myocardial iron concentration in patients with beta-thalassemia major

  2022cites this paper
• Hemoglobinopathies

  2022cites this paper
• Thalassaemia.

  2022cites this paper
• Identification of novel γ-globin inducers among all potential erythroid druggable targets

  2022cites this paper
• Early Detection of Iron Overload Cardiomyopathy in Transfusion Dependent Thalassemia Patients in Sulaimaniyah City, Iraq

  2022cites this paper
• [Cardiac imaging in infiltrative cardiomyopathies. What cardiovascular imaging modalities to propose in hypertrophic cardiomyopathies ?]

  2022cites this paper
• Myocardial T1, T2, T2*, and fat fraction quantification via low‐rank motion‐corrected cardiac MR fingerprinting

  2022influential citation
• Safety and Efficacy of the New Combination Iron Chelation Regimens in Patients with Transfusion-Dependent Thalassemia and Severe Iron Overload

  2022cites this paper